Please login to the form below

Not currently logged in
Email:
Password:

Philip Payne completes Concept Life Sciences’ leadership team

He joins as chief commercial officer

Philip PayneIntegrated drug discovery and analytical company, Concept Life Sciences has appointed Philip Payne as its chief commercial officer, completing the group’s leadership line up.

Payne will work with Concept’s executive team and board to drive the group’s commercial strategy, leading the business development function and helping to guide the next stage of the company’s growth.

He will manage the sales team, including identification of new service areas, geographies and markets, supporting the broadening of Concept’s reach into Europe and the US.

He said: “I am excited to join Concept at this pivotal stage in the growth of the company, and look forward to working with the team to meet the group’s commercial and strategic objectives.”

Following 27 years’ experience Payne’s expertise lies in managing business integration development and pharma and biotech analytical and development services.

He joins from Aptuit, where he held various roles including vice president of sales and was responsible for the global business development team and strategic accounts.

Prior to this, he was business development director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions.

Michael Fort, executive chairman, Concept Life Sciences, said: “Philip’s experience in managing multidisciplinary, international teams across a range of industries will be a great asset as Concept’s rapid rate of expansion continues.

“We are delighted to welcome Philip to the group.”

31st October 2017

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics